A Multicenter and Real-world Analysis of RC48-ADC in Patients With HER2-positive or HER2-low Expressing, Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT06168227 · COMPLETED
Trial details
- NCT number
- NCT06168227
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-10-01
- Primary completion
- 2023-06-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.